408 related articles for article (PubMed ID: 34379286)
1. Matrix metalloproteinase contribution in management of cancer proliferation, metastasis and drug targeting.
Abdel-Hamid NM; Abass SA
Mol Biol Rep; 2021 Sep; 48(9):6525-6538. PubMed ID: 34379286
[TBL] [Abstract][Full Text] [Related]
2. Physiological Properties, Functions, and Trends in the Matrix Metalloproteinase Inhibitors in Inflammation-Mediated Human Diseases.
Kim IS; Yang WS; Kim CH
Curr Med Chem; 2023; 30(18):2075-2112. PubMed ID: 36017851
[TBL] [Abstract][Full Text] [Related]
3. Biochemical and Biological Attributes of Matrix Metalloproteinases.
Cui N; Hu M; Khalil RA
Prog Mol Biol Transl Sci; 2017; 147():1-73. PubMed ID: 28413025
[TBL] [Abstract][Full Text] [Related]
4. Potential clinical applications of matrix metalloproteinase inhibitors and their future prospects.
Li W; Saji S; Sato F; Noda M; Toi M
Int J Biol Markers; 2013 Jun; 28(2):117-30. PubMed ID: 23787494
[TBL] [Abstract][Full Text] [Related]
5. Strategies to Target Matrix Metalloproteinases as Therapeutic Approach in Cancer.
Piperigkou Z; Manou D; Karamanou K; Theocharis AD
Methods Mol Biol; 2018; 1731():325-348. PubMed ID: 29318564
[TBL] [Abstract][Full Text] [Related]
6. [The role of metalloproteinases in modification of extracellular matrix in invasive tumor growth, metastasis and angiogenesis].
Fink K; Boratyński J
Postepy Hig Med Dosw (Online); 2012 Sep; 66():609-28. PubMed ID: 23001203
[TBL] [Abstract][Full Text] [Related]
7. Matrix metalloproteinases (MMPs), the main extracellular matrix (ECM) enzymes in collagen degradation, as a target for anticancer drugs.
Jabłońska-Trypuć A; Matejczyk M; Rosochacki S
J Enzyme Inhib Med Chem; 2016; 31(sup1):177-183. PubMed ID: 27028474
[TBL] [Abstract][Full Text] [Related]
8. Matrix Metalloproteinases, Vascular Remodeling, and Vascular Disease.
Wang X; Khalil RA
Adv Pharmacol; 2018; 81():241-330. PubMed ID: 29310800
[TBL] [Abstract][Full Text] [Related]
9. Matrix Metalloproteinases Inhibitors in Cancer Treatment: An Updated Review (2013-2023).
Almutairi S; Kalloush HM; Manoon NA; Bardaweel SK
Molecules; 2023 Jul; 28(14):. PubMed ID: 37513440
[TBL] [Abstract][Full Text] [Related]
10. Matrix metalloproteinases in tumor invasion.
Johansson N; Ahonen M; Kähäri VM
Cell Mol Life Sci; 2000 Jan; 57(1):5-15. PubMed ID: 10949577
[TBL] [Abstract][Full Text] [Related]
11. Structural and functional role of invariant water molecules in matrix metalloproteinases: a data-mining approach.
Kumar H; Mandal SK; Gogoi P; Kanaujia SP
J Biomol Struct Dyn; 2022; 40(20):10074-10085. PubMed ID: 34121627
[TBL] [Abstract][Full Text] [Related]
12. Pharmacodynamic considerations in the use of matrix metalloproteinase inhibitors in cancer treatment.
Yang JS; Lin CW; Su SC; Yang SF
Expert Opin Drug Metab Toxicol; 2016; 12(2):191-200. PubMed ID: 26852787
[TBL] [Abstract][Full Text] [Related]
13. Structure-based molecular insights into matrix metalloproteinase inhibitors in cancer treatments.
Lin H; Xu P; Huang M
Future Med Chem; 2022 Jan; 14(1):35-51. PubMed ID: 34779649
[TBL] [Abstract][Full Text] [Related]
14. Matrix metalloproteinases (MMPs) in health and disease: an overview.
Malemud CJ
Front Biosci; 2006 May; 11():1696-701. PubMed ID: 16368548
[TBL] [Abstract][Full Text] [Related]
15. Roles of matrix metalloproteinases in cancer progression and their pharmacological targeting.
Gialeli C; Theocharis AD; Karamanos NK
FEBS J; 2011 Jan; 278(1):16-27. PubMed ID: 21087457
[TBL] [Abstract][Full Text] [Related]
16. Seesaw of matrix metalloproteinases (MMPs).
Kapoor C; Vaidya S; Wadhwan V; ; Kaur G; Pathak A
J Cancer Res Ther; 2016; 12(1):28-35. PubMed ID: 27072206
[TBL] [Abstract][Full Text] [Related]
17. Matrix metalloproteinase and its drug targets therapy in solid and hematological malignancies: an overview.
Chaudhary AK; Pandya S; Ghosh K; Nadkarni A
Mutat Res; 2013; 753(1):7-23. PubMed ID: 23370482
[TBL] [Abstract][Full Text] [Related]
18. Next generation matrix metalloproteinase inhibitors - Novel strategies bring new prospects.
Levin M; Udi Y; Solomonov I; Sagi I
Biochim Biophys Acta Mol Cell Res; 2017 Nov; 1864(11 Pt A):1927-1939. PubMed ID: 28636874
[TBL] [Abstract][Full Text] [Related]
19. Molecular Imaging Probes Based on Matrix Metalloproteinase Inhibitors (MMPIs).
Rangasamy L; Geronimo BD; Ortín I; Coderch C; Zapico JM; Ramos A; de Pascual-Teresa B
Molecules; 2019 Aug; 24(16):. PubMed ID: 31426440
[TBL] [Abstract][Full Text] [Related]
20. Matrix metalloproteinases and cancer - roles in threat and therapy.
Yadav L; Puri N; Rastogi V; Satpute P; Ahmad R; Kaur G
Asian Pac J Cancer Prev; 2014; 15(3):1085-91. PubMed ID: 24606423
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
